Acipimox
Acipimox is a lipid regulating drug, belongs to nicotinic acid group. It reduces blood lipid level by inhibiting the release of fatty acids from fat tissues. Acipimox is used for the treatment of hyperlipidaemias of type IIa, IIb and IV in patients not responded adequately to diet and other appropriate measures.
Primary Characteristics
It is of Synthetic origin and belongs to Carboxylic acid.
Molecular Weight: 154.1 · pKa: 3.25 · Solubility in Water: 1 in 100 · Solubility in Alcohol: < 1 in 1000 · Non-proprietary name: Acipimox.

Pharmacokinetics
Absorption: Acipimox has an oral bioavailability is 45% (±45%).
Distribution: Acipimox has a volume of distribution is 0.3-0.4 l/kg. plasma protein binding is negligible.
Elimination: plasma half-life is 0.8-2.4 hr, renal excretion is 90% (unchanged).
Advertisement
Indications
Acipimox is primarily indicated in conditions like Hypertriglyceridaemia.
Contraindications
Acipimox is contraindicated in conditions like Peptic ulcer, Hypersensitivity.
Dosage
Acipimox's dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 625 mg/day | 625 mg/day | — | PO | In particular the lower dose is advised in type IV and the higher dose in types IIa and IIb hyperlipoproteinaemias. Daily dose should be divided and taken with main meals. |
| Paediatric Dosage (20kg) | ||||
| No data. | ||||
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Acipimox produces potentially life-threatening effects which include Bronchospasm , Bronchospasm, Angioedema , Anaphylactic reactions. Careful monitoring is needed with proper medical management.
Acipimox is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Dry eye, Epigastric pain, Flushing, Headache, Heart burn, Itching, Malaise, Nausea, Rashes , Urticaria.
Warnings / Precautions
Available Brands
Click on a strength to view available brands.
Single Ingredient
Storage Conditions
Drug Classification
- 1.12.6 — Lipid-regulating drugs /Anti-atheromas
Manufacturers
Manufacturers of Acipimox in Pakistan: